AbbVie Declares Quarterly Dividend
The board of directors of AbbVie Inc. (NYSE: ABBV) has recently declared a significant quarterly cash dividend of $1.64 per share. This decision underscores the company’s commitment to providing value to its investors, reflecting steady financial health and robust operational performance.
Dividend Payment Details
The declared cash dividend will be payable on a specified date to stockholders who are on record as of the close of business on another designated date. This structured approach ensures that shareholders are well-informed and can anticipate their returns. Such transparency is part of AbbVie's philosophy to maintain a strong relationship with its investors.
Growth in Dividends Over the Years
Since its establishment, AbbVie has impressively increased its dividend by 310 percent, a testament to its ongoing financial success. This growth in dividends reflects the company’s strategy and performance, placing it among the S&P Dividend Aristocrats Index, which includes companies that have consistently raised their dividends for a remarkable 25 consecutive years or more.
Financial Stability and Investor Confidence
AbbVie’s commitment to increasing dividends reinforces its financial stability and strengthens investor confidence. This is particularly important as the company navigates the complexities of the pharmaceutical industry while continuing to innovate and expand its product offerings.
About AbbVie
AbbVie's mission revolves around discovering and delivering innovative medicines and solutions that address serious health issues currently faced and those anticipated in the future. The company strives to leave a profound impact on various therapeutic areas including but not limited to immunology, oncology, neuroscience, and eye care. Additionally, it offers products and services within its Allergan Aesthetics portfolio, contributing to a broader spectrum of healthcare solutions.
For more information about AbbVie and its initiatives, interested parties can visit their official website and follow them on social media platforms such as LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Contact Information
For media inquiries, Gabby Tarbert can be reached at (224) 244-0111, while investor relations can be directed to Liz Shea at (847) 935-2211. This clear line of communication is part of AbbVie’s effort to maintain transparency and accessibility for stakeholders.
Frequently Asked Questions
What is the amount of AbbVie's quarterly dividend?
AbbVie has declared a quarterly cash dividend of $1.64 per share.
When is the dividend payment date?
The dividends will be payable on a specified date to shareholders recorded by another specified deadline.
How much has AbbVie increased its dividend since 2013?
Since its inception in 2013, AbbVie has increased its dividend by 310 percent.
What is the significance of AbbVie being part of the S&P Dividend Aristocrats Index?
Being included in the S&P Dividend Aristocrats Index signifies that AbbVie has increased its dividend for at least 25 consecutive years, reflecting consistent financial growth and commitment to shareholders.
How does AbbVie ensure investor communication?
AbbVie provides clear contact information for media and investors, enhancing transparency and communication regarding company performance and initiatives.
